Inventor profile of:

Zhihong Li

City:

Millbrae, California

Country:

United States

Published Applications:

29

Last publication date:

2026-03-19

Top Assignees for applications by Zhihong Li

The entities that hold a legal rights for patent applications filed by inventor Li Zhihong:

Recent patent applications by Li Zhihong

Zhihong Li from Millbrae, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-19
US20260078091A1
Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#2 | 2025-01-30
US20250034197A1
Chemistry; metallurgy

NUCLEOSIDE-DIPHOSPHATE-HEPTOSE COMPOUNDS FOR TREATING CONDITIONS ASSOCIATED WITH ALPK1 ACTIVITY

#3 | 2024-09-12
US20240300892A1
Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#4 | 2022-06-02
US20220169611A1
Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#5 | 2022-02-22
US16640508
Chemistry; metallurgy

Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor

#6 | 2021-07-29
US20210230189A1
Chemistry; metallurgy

Compounds that inhibit MCL-1 protein

#7 | 2021-06-17
US20210179560A1
Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#8 | 2020-03-12
US20200079793A1
Chemistry; metallurgy

COMPOUNDS AND METHODS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADENOSINE A2A RECEPTOR

#9 | 2019-02-28
US20190062276A1
Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#10 | 2019-01-24
US20190023720A1
Chemistry; metallurgy

Compounds that inhibit MCL-1 protein

#11 | 2019-01-17
US20190016736A1
Chemistry; metallurgy

Compounds that inhibit Mcl-1 protein

#12 | 2018-03-29
US20180087079A1
Chemistry; metallurgy

METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROPERTIES OF A CELL CULTURE

#13 | 2017-05-25
US20170144971A1
Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#14 | 2017-03-30
US20170088560A1
Chemistry; metallurgy

Compounds that inhibit Mcl-1 protein

#15 | 2016-12-22
US20160368933A1
Chemistry; metallurgy

FUSED TRICYCLIC DUAL INHIBITORS OF CDK 4/6 AND FLT3

#16 | 2016-05-19
US20160137667A1
Chemistry; metallurgy

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

#17 | 2016-03-10
US20160068545A1
Chemistry; metallurgy

Compounds that inhibit MCL-1 protein

#18 | 2015-12-10
US20150353542A1
Chemistry; metallurgy

METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROPERTIES OF A CELL CULTURE

#19 | 2014-11-27
US20140350244A1
Chemistry; metallurgy

Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors

#20 | 2014-10-23
US20140315895A1
Chemistry; metallurgy

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

#21 | 2014-08-21
US20140235629A1
Chemistry; metallurgy

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer

#22 | 2014-07-17
US20140199728A1
Chemistry; metallurgy

METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROPERTIES OF A CELL CULTURE

#23 | 2014-06-12
US20140163052A1
Chemistry; metallurgy

Fused tricyclic dual inhibitors of CDK 4/6 and FLT3

#24 | 2014-01-09
US20140011796A1
Chemistry; metallurgy

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER

#25 | 2012-09-27
US20120244110A1
Chemistry; metallurgy

Fused tricyclic dual inhibitors of CDK 4/6 and FLT3

#26 | 2011-12-29
US20110319378A1
Chemistry; metallurgy

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

#27 | 2011-06-16
US20110142796A1
Chemistry; metallurgy

Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors

#28 | 2011-04-28
US20110097305A1
Chemistry; metallurgy

Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors

#29 | 2011-04-14
US20110086834A1
Chemistry; metallurgy

ALKYNYL ALCOHOLS AS KINASE INHIBITORS

InventorID:

606418 ⎘